Dafda, A., Singh, N. R., & Chhabra, A. (2024). Effectiveness and safety of daily versus alternate-day rosuvastatin dose in dyslipidemic patients: a prospective, randomized and open-label study. International Journal of Basic & Clinical Pharmacology, 14(1), 50–54. https://doi.org/10.18203/2319-2003.ijbcp20243835